Childhood cancers trials in Netherlands
120 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleNovel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
- Where
- Amsterdam
- People
- 100
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT07511933 - Phase 3Taking peopleFight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
- Where
- Groningen, Leiden, Nijmegen, Utrecht
- People
- 508 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-505575-69-01 - Phase 1/2Taking peopleEuropean Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Where
- Utrecht
- Age
- Up to 18 years
- People
- 472 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT02813135 · EU 2024-514791-40-00 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Amsterdam, Delft, Groningen, Leidschendam, Nijmegen
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - Early phase 1Taking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Utrecht
- Age
- 1 year to 21 years
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - Phase 1/2Not yet taking people in NetherlandsFIDES: Focused Ultrasound-mediated Blood-Brain Barrier Opening In Pontine Diffuse Midline Glioma (DMG) to Enhance Systemic Therapy with Temozolomide – an exploratory pilot and feasibility trial
- Where
- Utrecht
- Age
- Up to 64 years
- People
- 20
- Run by
- Universitair Medisch Centrum Utrecht
See details and how to join2025-520814-78-00 - Phase 2Taking peopleCombination Therapy for the Treatment of Diffuse Midline Gliomas
- Where
- Utrecht
- Age
- 2 years to 39 years
- People
- 360 worldwide
- Run by
- University of California, San Francisco
See details and how to joinNCT05009992 · EU 2023-507598-16-00 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Amsterdam, Groningen, Maastricht, Nijmegen
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - Phase 1Taking peopleONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- Where
- Utrecht
- Age
- 2 years to 21 years
- People
- 208 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT04732065 · EU 2025-521180-13-00 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Groningen, Utrecht
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - No phaseNot yet taking people in NetherlandsLate Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.
- Where
- Groningen
- Age
- 16 years and over
- People
- 8
- Run by
- University Medical Center Groningen
See details and how to joinNCT07627269 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Amsterdam, Groningen
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 2Taking peopleIntratumoral DNX-2401 for High Grade Pediatric Brain Tumors
- Where
- Utrecht
- Age
- 1 year to 25 years
- People
- 39 worldwide
- Run by
- Clinica Universidad de Navarra, Universidad de Navarra
See details and how to joinNCT07424092 · EU 2024-515009-24-00 - Phase 2Taking peopleTimely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: A Randomized Trial
- Where
- Amersfoort, Gouda, Leiden, Nijmegen
- People
- 246
- Run by
- Roxanne Gal
See details and how to joinNCT06805396 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Utrecht
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 - Phase 1/2Taking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Utrecht
- Age
- Up to 64 years
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 - Phase 3Taking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Utrecht
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - No phaseTaking peopleCancer Of the BReast Asanas Study (COBRA)
- Where
- Utrecht
- People
- 140
- Run by
- UMC Utrecht
See details and how to joinNCT06480513 - Phase 2Taking peopleSafety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
- Where
- Utrecht
- Age
- 6 months to 17 years
- People
- 31 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508931 · EU 2023-506348-17-00 - Phase 2Taking peopleIndocyanine Green and near infrared fLuorescence in paediatric Oncology surgery
- Where
- Utrecht
- People
- 30
- Run by
- The University Of Birmingham
See details and how to join2024-514089-37-00 - Phase 2Taking peopleTovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
- Where
- Utrecht
- Age
- 1 year to 39 years
- People
- 57 worldwide
- Run by
- Sabine Mueller, MD, PhD
See details and how to joinNCT05465174 · EU 2024-511510-20-00 - Phase 3Taking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Rotterdam, Utrecht
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - Phase 3Taking peopleNO Re-excision MelanomA - NORMA 2
- Where
- Alkmaar, Almere Stad, Amsterdam, Apeldoorn, Arnhem, Eindhoven, Enschede, Gouda, Groningen, Hilversum, Hoorn, Leiden, Maastricht, Rotterdam, 's-Hertogenbosch, The Hague, Utrecht, Zwolle
- People
- 1,749
- Run by
- Marieke Goodijk
See details and how to joinNCT07530887 - Phase 2Taking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Utrecht
- Age
- Up to 17 years
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - Phase 2Taking peopleA study to determine how safe MB-CART2019.1 is and how well it works in children and adolescents with B cell neoplasms
- Where
- Utrecht
- Age
- Up to 17 years
- People
- 12 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT06508951